High-risk breast cancer detection linked to patient prognosis: Study
Analysis of results from over eight years` follow-up of the international MINDACT randomised phase III clinical trial shows that although tumours may have the same genetic make-up, the way they are detected makes a significant difference to the period of time before the disease starts spreading to other parts of the body or results in death, whichever comes first.
Oct 05, 2020, 18:40 PM IST